Home
/ Medite
/ Competitors

Medite Competitors and Similar CompaniesClear all

Medite's competitors and similar companies include Sensus Healthcare, Immuno Diagnostic, Novartis UK and Berry Oncology.

	Medite Medite Cancer Diagnostics (formerly CytoCore) is a company that specializes in the development, manufacture and distribution of medical laboratory instruments for pathology, histology, and cytology.	Sensus Healthcare Sensus Healthcare is focused on developing proven non-melanoma skin cancer solutions.	Immuno Diagnostic Immuno Diagnostic is a provider of products for research, clinical diagnostics, and hospitals.	Novartis UK Novartis UK is a developer, manufacturer, and marketer of medicines and devices.	Berry Oncology Berry Oncology is a company that develops medical technology intended to improve cancer prevention and tumor diagnosis.
Founding Date	Founding Date 1998	Founding Date 2010	Founding Date 1983	Founding Date N/A	Founding Date 2017
Type	Type Public	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare Manufacturing & Industrial medical devices oncology	Tags Healthcare medical devices oncology	Tags Healthcare medical devices oncology	Tags Healthcare medical devices oncology	Tags Healthcare medical devices oncology
Locations	Locations Orlando, US HQ Burgdorf, DE	Locations Boca Raton, US HQ Giv'atayim, IL	Locations Hämeenlinna, FI HQ Espoo, FI	Locations London, GB HQ	Locations HQ
Employees	Employees 696% increase	Employees 5310% increase	Employees 12	Employees 2751% increase	Employees N/A
Valuation ($)	Valuation ($) 520.3 k	Valuation ($) 113.9 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $6.8m (FY, 2017)	Revenue (est.) $27.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $6.7m (FY, 2017)	Cost of goods $15.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $162k (FY, 2017)	Gross profit $11.9m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($6.8m) (FY, 2017)	Net income ($7.7m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1.4m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 337.9m